Literature DB >> 14569068

Interaction of cyclooxygenase isoenzymes, nitric oxide, and afferent neurons in gastric mucosal defense in rats.

Karlheinz Ehrlich1, Christa Sicking, Michael Respondek, Brigitta M Peskar.   

Abstract

The cyclooxygenase (COX)-2 inhibitors 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5II)-furanone (DFU) (0.02-2 mg/kg) and N-[2-(cyclohexyloxy)-4-nitrofenyl]-methanesulfonamide (NS-398) (0.01-1 mg/kg), the COX-1 inhibitor 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole (SC-560) (0.05-5 mg/kg), and dexamethasone (1 mg/kg) were studied in rats challenged with intragastric acid (300 mM HCl). All compounds induced severe gastric damage when rats were treated concurrently with the inhibitor of constitutive and inducible nitric-oxide (NO) synthase N(G)-monomethyl-L-arginine methyl ester (L-NAME) (3 or 40 mg/kg). DFU and NS-398 caused significantly less damage in rats receiving the selective inhibitor of inducible NO synthase N-(3-(aminomethyl)benzyl)acetamidine (1400W) (0.3 mg/kg). The COX-1 inhibitor SC-560 induced moderate damage in the acid-challenged stomach even without suppression of NO, but damage was aggravated by L-NAME. The COX-3 inhibitor phenacetin (400 mg/kg) did not injure the gastric mucosa despite suppression of NO. Furthermore, DFU, NS-398, SC-560, and dexamethasone caused severe injury in the acid-challenged stomach of rats pretreated with capsaicin to ablate afferent neurons. The mucosal damage induced by the COX-1 inhibitor, the COX-2 inhibitors, and dexamethasone in L-NAME- or capsaicin-treated rats was reversed by coadministration of 16,16-dimethyl-prostaglandin E2 (2 x 8 ng/kg). Gross mucosal damage was paralleled by histology. Our results support the concept that endogenous NO, prostaglandins, and afferent neurons act in concert in the regulation of gastric mucosal integrity. The prostaglandins necessary for mucosal defense in the face of NO suppression, and afferent nerve ablation can be derived either from COX-1 or COX-2. The data do not propose a protective role for a phenacetin-sensitive COX-3. Our findings suggest that not only COX-1 but also COX-2 has important functions in the maintenance of gastric integrity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569068     DOI: 10.1124/jpet.103.057752

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Gastroprotective action of glucocorticoid hormones in rats with desensitization of capsaicin-sensitive sensory neurons.

Authors:  P Bobryshev; T Bagaeva; L Filaretova
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 2.  Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing.

Authors:  Brigitta M Peskar
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 3.  Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.

Authors:  John L Wallace; Pallavi R Devchand
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  Role of capsaicin-sensitive primary afferent neurons and non-protein sulphydryl groups on gastroprotective effect of amifostine against ethanol-induced gastric damage in rats.

Authors:  Jerônimo Junqueira-Júnior; Ana Flávia Torquato Araújo Junqueira; Jand Venes R Medeiros; Sergio Henrique Brito Barbosa; Ana Carolina Pereira Nogueira; José Maurício Segundo Correia Mota; Ana Paula Macêdo Santana; Gerly Anne C Brito; Ronaldo A Ribeiro; Roberto César P Lima-Júnior; Marcellus H L P Souza
Journal:  Dig Dis Sci       Date:  2010-06-16       Impact factor: 3.199

5.  Effect of astragaloside IV on diabetic gastric mucosa in vivo and in vitro.

Authors:  Ningding Wang; Frederick Siu; Yongbin Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  Activation of the hypothalamo-hypophyseal-adrenocortical system as an important gastroprotective component of the stress reaction.

Authors:  L P Filaretova
Journal:  Neurosci Behav Physiol       Date:  2007-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.